Hangzhou Third Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2015
NCT04202068
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Hangzhou Third Hospital | Hangzhou Third People's Hospital | The third people's hospital of Hangzhou

Active Ingredients

Drugs in Phase 4 Trials (2)

ceftriaxone (rocephin) (1 trial)

sulbactam (unasyn) (1 trial)

Drugs in Phase 2 Trials (2)

anlotinib (1 trial)

hs-10374 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gonorrhea (Phase 4)

Sarcoma (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4